Vista Pharmaceuticals Ltd

₹ 6.44 2.22%

21 Aug - close price

About

Incorporated in 1992, Vista Pharmaceuticals
Ltd manufactures and sells pharmaceutical, medical and veterinary preparations^[1]

Key Points

Business Overview:^[1]^[2]
a) The company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories and veterinary preparations
b) It manufactures pharmaceutical drugs such as sulphamethoxazole, trimethoprim
and isoxsuprime.
c) The company also sells its products to related companies (Common Directors) engaged in manufacturing formulations

Website BSE

Market Cap ₹ 39.6 Cr.
Current Price ₹ 6.44
High / Low ₹ 10.8 / 5.71
Stock P/E
Book Value ₹ 5.92
Dividend Yield 0.00 %
ROCE -30.3 %
ROE -29.5 %
Face Value ₹ 2.00

Add ratio to table

Edit ratios

Pros

Stock is trading at 1.09 times its book value
Debtor days have improved from 347 to 21.6 days.

Cons

Company has low interest coverage ratio.
Promoter holding is low: 21.2%
Company has a low return on equity of -17.1% over last 3 years.
Promoter holding has decreased over last 3 years: -9.29%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1.98	3.47	1.70	3.13	1.80	2.49	2.56	3.23	1.52	1.46	2.42	0.00	0.00
	2.90	4.64	3.44	2.87	2.58	3.32	4.08	4.14	2.63	4.89	5.42	7.06	0.84
Operating Profit	-0.92	-1.17	-1.74	0.26	-0.78	-0.83	-1.52	-0.91	-1.11	-3.43	-3.00	-7.06	-0.84
OPM %	-46.46%	-33.72%	-102.35%	8.31%	-43.33%	-33.33%	-59.38%	-28.17%	-73.03%	-234.93%	-123.97%
	0.13	0.08	0.02	0.10	0.07	0.01	0.12	0.24	0.00	0.19	0.09	0.03	0.04
Interest	0.33	0.32	0.30	0.28	0.28	0.25	0.22	0.21	0.19	0.18	0.18	0.55	0.34
Depreciation	0.17	0.18	0.18	0.18	0.18	0.18	0.19	0.18	0.18	0.20	0.19	0.19	0.19
Profit before tax	-1.29	-1.59	-2.20	-0.10	-1.17	-1.25	-1.81	-1.06	-1.48	-3.62	-3.28	-7.77	-1.33
Tax %	-25.58%	27.04%	-25.91%	-190.00%	-26.50%	-22.40%	-26.52%	40.57%	-12.84%	-28.45%	-29.27%	-24.58%	-25.56%
	-0.95	-2.02	-1.63	0.09	-0.86	-0.97	-1.32	-1.50	-1.29	-2.59	-2.32	-5.86	-0.99
EPS in Rs	-0.26	-0.55	-0.44	0.02	-0.23	-0.26	-0.36	-0.41	-0.21	-0.42	-0.38	-0.95	-0.16
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	14	15	24	29	31	23	1	0	1	10	10	5	4
	11	13	21	24	30	28	3	2	5	13	14	20	18
Operating Profit	3	3	3	5	1	-5	-2	-1	-4	-3	-4	-15	-14
OPM %	20%	17%	13%	18%	4.0%	-21%	-136%	-326%	-432%	-33%	-41%	-271%	-369%
	0	0	0	0	3	4	0	0	0	0	0	0	0
Interest	0	1	1	2	2	2	2	1	1	1	1	1	1
Depreciation	1	1	1	1	1	1	1	1	1	1	1	1	1
Profit before tax	1	1	1	3	1	-4	-4	-3	-6	-5	-5	-16	-16
Tax %	-9%	8%	-2%	23%	18%	-7%	-47%	-66%	-4%	-13%	-12%	-25%
	1	1	1	2	1	-4	-2	-1	-6	-5	-5	-12	-12
EPS in Rs	0.11	0.06	0.47	0.75	0.31	-1.21	-0.55	-0.24	-1.54	-1.23	-1.26	-1.96	-1.91
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	-10%
5 Years:	34%
3 Years:	75%
TTM:	-60%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-132%

Stock Price CAGR
10 Years:	-12%
5 Years:	-6%
3 Years:	-21%
1 Year:	-38%

Return on Equity
10 Years:	-9%
5 Years:	-14%
3 Years:	-17%
Last Year:	-29%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	5	5	5	6	6	6	7	7	8	9	12	12
Reserves	5	6	11	26	30	24	25	28	29	31	33	24
	4	8	11	11	11	15	11	13	10	8	7	10
	8	7	14	10	6	6	9	8	9	10	7	9
Total Liabilities	23	26	42	53	53	51	53	56	56	58	60	55
	11	10	13	18	21	21	20	19	20	19	19	18
CWIP	0	0	2	7	9	9	9	9	9	10	10	11
Investments	0	0	0	0	0	0	0	0	0	0	0	0
	12	16	26	28	24	22	24	27	27	29	31	26
Total Assets	23	26	42	53	53	51	53	56	56	58	60	55

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-4	-2	3	-5	3	1	-7	-1	-2	-5	-7	-4
	-0	-0	-4	-11	-6	-2	-0	-0	-1	-1	-0	-1
	4	3	6	11	1	0	7	1	3	6	8	5
Net Cash Flow	0	0	5	-4	-1	-1	-0	-0	0	-0	1	-1
Free Cash Flow	-4	-3	-1	-15	-2	-1	-7	-1	-3	-6	-7	-5
CFO/OP	-131%	-89%	84%	-86%	299%	-17%	390%	78%	64%	149%	163%	30%

Ratios

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	300	231	136	137	98	165	624	9,789	4,106	515	505	22
Inventory Days	10	97	185	250	162	148	4,840	9,204	991	279	359	770
Days Payable	359	236	293	209	76	79	2,555	5,297	1,007	304	244	443
Cash Conversion Cycle	-50	92	27	178	184	234	2,909	13,696	4,089	490	620	349
Working Capital Days	-8	206	12	137	137	81	1,681	10,154	3,460	318	440	-95
ROCE %	14%	10%	9%	12%	6%	-5%	-5%	-4%	-10%	-8%	-9%	-30%

Insights

In beta

Mar 2016

Mar 2017

Mar 2018

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Export sales (FOB value)
Rs Lakhs

xxx.xx	x,xxx.xx		xxx.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx
xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx
xx,xxx	xx,xxx	xx,xxx	x,xxx	x,xxx	x,xxx
xx	xx	xx	xx	xx	xx
xxx.xx	xxx.xx		xxx.xx	xxx.xx

Please log in to see hidden values.

Electricity purchased
KWH

Furnace oil (diesel for boiler)
Liters

Number of permanent employees
count

Expenditure on products under development (additions)
Rs Lakhs

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	29.51%	27.81%	27.81%	21.19%	21.19%	21.19%	21.19%	21.19%	21.19%	21.19%	21.19%	21.19%
	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
	70.46%	72.16%	72.16%	78.79%	78.79%	78.79%	78.78%	78.78%	78.78%	78.78%	78.80%	78.80%
No. of Shareholders	14,250	13,908	14,015	13,882	13,913	14,086	14,158	14,061	14,012	14,080	14,154	14,154

	Mar 2016	Dec 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	26.87%	26.87%	35.56%	38.14%	38.14%	35.29%	35.44%	35.44%	27.81%	21.19%	21.19%	21.19%
	0.00%	0.00%	0.31%	0.30%	0.30%	0.24%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.06%	0.06%	0.05%	0.04%	0.04%	0.04%	0.04%	0.04%	0.03%	0.02%	0.02%	0.02%
	73.07%	73.07%	64.08%	61.51%	61.51%	64.43%	64.52%	64.52%	72.16%	78.78%	78.80%	78.80%
No. of Shareholders	10,618	10,892	11,595	11,510	11,340	11,643	14,380	14,796	14,015	14,158	14,154	14,154

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Vista Pharmaceuticals Ltd

Vista Pharmaceuticals Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings